NIH-funded research Sbir 1 grant

AKT1 mutation detection in breast cancer with AI on standard pathology slides

Official title: Analytical Variables and Clinical Utility of AKT1 Mutation Prediction in Breast Cancer Using Deep Learning on Histopathology Images

Funded at Imagenomix Corp. · NIH-11312149 · Data updated 2026-11-12

A new AI tool called AKT Predict aims to quickly and cheaply identify AKT1 mutations in breast cancer using regular pathology slides.

More Breast Cancer research and trials

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionImagenomix Corp.
NIH-funded
Lab location1 site (Brooklyn, United States)
Project startSeptember 18, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$157,826
NIH project number1R43CA309961-01
Project IDNIH-11312149 on NIH RePORTER

Who could benefit from this research

Could help

Breast cancer patients whose tissue slides are used for diagnostic pathology and who may be candidates for AKT1-targeted therapies or related trials.

Less likely to help

Patients whose tumors do not harbor AKT1 mutations or whose samples are inadequate for AI analysis may not benefit.

What this research studies

This project will develop and test a deep learning algorithm that analyzes routine H&E slides to predict AKT1 mutations, reducing the need for additional tissue sampling. It seeks to validate how well the AI can detect mutations across breast cancer samples and potentially other actionable mutations. If successful, this could speed up patient enrollment in targeted therapy trials and broaden access to molecular screening.

Why it matters

Potential benefit: If successful, patients could receive faster, cheaper mutation screening to guide targeted therapies.

How similar studies have gone: AI-based pathology analysis has shown promise in mutation prediction, but this specific AKT1-focused approach is novel and requires validation.

Where this research is happening

  • Imagenomix Corp.
    Brooklyn, United States
    Active

Researchers

  • Principal investigator: Teverovskiy, Mikhail — Imagenomix Corp.
  • Study coordinator: Teverovskiy, Mikhail

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.